Intellia Therapeutics Q2 Net Income USD -106.634 Million
NTLA•Q2 results
Aug. 6 (Reuters) - Intellia Therapeutics Q2 collaboration revenue was $7.659 million.
- Q2 basic EPS: $-0.8
- Q2 operating expenses: $120.419 million
- Q2 operating income: $-112.76 million



